Collaboration Combines CollPlant's Proprietary rhCollagen-based Bioink Technology and United Therapeutics' Regenerative Medicine and Organ Manufacturing Capabilities
NESS ZIONA, Israel and SILVER SPRING, Md., Oct. 22...
16 Oct 2018
United Therapeutics And MannKind Announce Closing Of License And Collaboration Agreement
RESEARCH TRIANGLE PARK, N.C. and WESTLAKE VILLAGE, Calif., Oct. 16, 2018 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) and MannKind Corporation (Nasdaq: MNKD) today announced the closing of their pending...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 18, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will host Science Day 2018 in New York City on Monday, September...
17 Sep 2018
Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
SAN DIEGO and SILVER SPRING, Md., Sept. 17, 2018 /PRNewswire/ -- Samumed LLC has entered an exclusive license agreement with United Therapeutics Corporation (Nasdaq: UTHR) for North American rights to Samumed's SM04646...
04 Sep 2018
United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products
Exclusive license agreement for Treprostinil Technosphere®; $95 million in upfront and milestone payments
Research agreement for additional products for additional $10 million
SILVER SPRING, Md. and WESTLAKE VILLAGE...
SILVER SPRING, Md., Aug. 30, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) ("United Therapeutics") today announced that it has closed the merger of SteadyMed Ltd. (NASDAQ: STDY) ("SteadyMed") with a...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 8, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Watson Laboratories...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 8, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that preliminary analysis indicates that the FREEDOM-EV clinical study of...
07 Aug 2018
United Therapeutics Corporation To Present At 2018 Wedbush PacGrow Healthcare Conference
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 7, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 1, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the quarter ended June 30, 2018."Our second...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 31, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA) of a New Drug...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 26, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its second quarter 2018 financial results before the...